Life Science Company News

Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Avalo Reports 2022 Financial Results and Provides Business Updates

Read more ››
By: GlobenewsWire - 29 Mar 2023

PolyPid Announces Pricing of $6.2 Million Underwritten Public Offering of Ordinary Shares and Concurrent $4.4 Million Private Placement of Pre-Funded Warrants

Read more ››
By: GlobenewsWire - 29 Mar 2023

Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need

Read more ››
By: GlobenewsWire - 29 Mar 2023

Poland and U.K. Regulatory Authorities – URPL and MHRA – Approve Use of New, Higher-Yielding Manufacturing Process for Nomacopan in Pivotal Clinical Study

Read more ››
By: GlobenewsWire - 29 Mar 2023

QIAGEN’s QIAxcel Connect wins Red Dot design award

Read more ››
By: GlobenewsWire - 29 Mar 2023

Cocrystal Pharma Reports 2022 Financial Results and Provides Updates on its Antiviral Drug Development Programs

Read more ››
By: GlobenewsWire - 29 Mar 2023

RAPT Therapeutics Announces Initiation of Phase 2a Trial of RPT193 in Patients with Moderate-to-Severe Asthma

Read more ››
By: GlobenewsWire - 29 Mar 2023

Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation

Read more ››
By: GlobenewsWire - 29 Mar 2023

Vaxart to Present at World Vaccine Congress Washington 2023 on April 5-6

Read more ››
By: GlobenewsWire - 29 Mar 2023

CRISPR Therapeutics Announces Departure of Board Member

Read more ››
By: GlobenewsWire - 29 Mar 2023

Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor

Read more ››
By: GlobenewsWire - 29 Mar 2023

Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days

Read more ››
By: GlobenewsWire - 29 Mar 2023

BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article

Read more ››
By: GlobenewsWire - 29 Mar 2023

ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event

Read more ››
By: GlobenewsWire - 29 Mar 2023

Axial Therapeutics Announces Key Research and Development Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics

Read more ››
By: GlobenewsWire - 29 Mar 2023

Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results

Read more ››
By: GlobenewsWire - 29 Mar 2023

BioCardia Reports Fourth Quarter and Full Year 2022 Business Highlights and Financial Results

Read more ››
By: GlobenewsWire - 29 Mar 2023

Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023

Read more ››
By: GlobenewsWire - 29 Mar 2023

Milestone Scientific Schedules 2022 Year-End Financial Results and Business Update Conference Call

Read more ››
By: GlobenewsWire - 29 Mar 2023

Aquestive Therapeutics Expands License and Supply Agreement with Pharmanovia for Libervant™ (diazepam) Buccal Film to Additional Global Markets

Read more ››
By: GlobenewsWire - 29 Mar 2023
Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate